JUN 23, 2018 05:31 AM PDT

Algorithm-Based Blood Test Diagnoses Autism

WRITTEN BY: Kara Marker

As a developmental disorder, autism spectrum disorders (ASD) can be diagnosed as early as 18 to 24 months of age, but often the diagnosis does not come until a child is four years old. This is due to a dependence on clinical observations, but a new Rensselaer Polytechnic Institute shows the promising opportunity for an algorithm-based blood test to help clinicians make an ASD diagnosis as early as possible.

One year after researchers published their work on a physiological test for autism, a follow-up study confirms its exceptional success in assessing whether a child is on the autism spectrum. Credit: Rensselaer

ASD is defined as a developmental disorder affecting communication and behavior, with those affected having difficulty in various social situations:

  • Interaction with other people
  • Restricted interests and repetitive behaviors
  • Inability to function normally in school, work, and other social contexts

Just under two percent of children are diagnosed with autism, and when children are diagnosed early in life, they receive the opportunity to engage in early intervention services. Treatment for ASD can be used for relieving irritability, aggression, repetitive behavior, hyperactivity, attention problems and anxiety and depression. Children diagnosed with ASD can also benefit from behavioral, psychological, and educational therapy.

Lead author Juergen Hahn developed his algorithm-based test not to take over as the reigning technique for diagnosing ASD, but to accompany a clinician’s diagnostic process to diagnose children as early as possible. The test is based on specific metabolites identifiable in a blood sample. Hahn says the test is “extremely promising.”

As opposed to looking for just one major biomarker indicative of ASD, Hahn set out to look for a panel of metabolites that were linked to two cellular pathways already associated with ASD: the methionine cycle and the transsulfuration pathway. His 2017 study included data from 149 people, half of which had already been diagnosed with ASD.

Hahn analyzed data on 24 metabolites related to the two pathways and used his results to design a predictive algorithm. Then, he used that algorithm to correctly identify 96.1 percent of all typically developing participants and 97.6 with an ASD diagnosis.

In the new study, Hahn tested the algorithm in a fresh dataset, containing data from 154 children with ASD. The predictive algorithm correctly identified autism with 88 percent accuracy. The reason for the missing percentage points? In the new study, only 22 out of the 24 original metabolites were included.

"The most meaningful result is the high degree of accuracy we are able to obtain using this approach on data collected years apart from the original dataset," Hahn concluded. "This is an approach that we would like to see move forward into clinical trials and ultimately into a commercially available test."

The present study was published in the journal Bioengineering & Translational Medicine.

Sources: National Institute of Mental Health, Rensselaer Polytechnic Institute

 

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
APR 29, 2018
Genetics & Genomics
APR 29, 2018
CRISPR Can Now Edit Genes Outside of the Cell
The CRISPR/Cas9 gene-editing tool was made from an immune defense system used by bacteria. Scientists have found it has many applications....
JUN 14, 2018
Clinical & Molecular DX
JUN 14, 2018
Automated Blood Drawing Device Coming to Your Doctor's Office
A robot arm could soon be coming to your doctor’s office to take your blood and analyze it for you. From scientists at Rutgers University, this techn...
JUN 30, 2018
Immunology
JUN 30, 2018
CD4 T Cells Responsible for Inflammatory Bowel Disease
A specific subset of immune cells could be targeted to better treat inflammatory bowel disease (IBD). A new University of Alabama at Birmingham study point...
JUL 11, 2018
Clinical & Molecular DX
JUL 11, 2018
Certain tests better flag fetuses with brain disorder risk
Fetuses with a specific, rare chromosomal aberration have a 20 percent risk of developmental or other brain disorder, new research shows. The work could le...
JUL 20, 2018
Chemistry & Physics
JUL 20, 2018
X-ray Images to Get Colors
In the near future, the X-ray images from your doctor's office will no longer be just black and white, at least that's what MARS Bioimaging Ltd, an...
AUG 11, 2018
Microbiology
AUG 11, 2018
A Microbrewery can Help us Monitor Radiation Exposure
This wearable technology is very sensitive, and can be used by workers that are at risk of radiation exposure....
Loading Comments...